REG - Camellia PLC - Final Results
Wed 07:00
For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250430:nRSd7193Ga&default-theme=true
RNS Number : 7193G Camellia PLC 30 April 2025
30 April 2025
Camellia Plc
('Camellia', the 'Company')
Final Results for the 12 months ended 31 December 2024
'Laying the foundations to support value creation and sustainable
profitability'
Camellia is pleased to announce its Final Results for the 12 months ended 31
December 2024.
2024 was an important transitional year for the Company. The leadership team
and Board were strengthened, and progressed a comprehensive business review.
Additionally, financial liquidity was significantly improved, and inherent
business risk reduced. The actions taken by the Board represent the first
steps to increasing the business's value and returning it to operating
profitability.
About Camellia:
Camellia is the ultimate holding company of a portfolio of international
businesses and assets, with its core operating companies focused on
agriculture through the growing of tea, avocado, macadamia and arable crops
(the "Group"). The operating companies in the Group own and manage almost
50,000 hectares of land across three continents. Camellia's fundamental
objective is to invest sustainably for the long-term to deliver attractive
returns to shareholders, operating in harmony with the natural environment and
supporting the many communities of people its operating companies sustain.
2024 Financial Highlights:
· Financial results reflect an improvement in market conditions in
the Group's core agricultural products in 2024 compared to 2023, albeit
trading conditions remained difficult across many markets
· Balance sheet significantly strengthened through disposals of
non-core assets and operations, with net cash, treasury deposits and money
market instruments totalling £124.7 million (2023: £32.5 million)
· Revenue from continuing operations increased 3% to £262.2
million (2023: £254.2 million)
· Trading loss improved to £5.5 million (2023: loss of £10.3
million)
· Loss attributable to shareholders of £4.9 million (2023: loss of
£3.7 million)
· The Directors have proposed a final ordinary dividend of 260p
subject to shareholder approval at the AGM, making a total dividend in respect
of the 2024 financial year of 260p (2023: Nil)
2024 Operational Highlights:
· Strengthened Board and leadership team and progressed a
comprehensive review of the Group
· Group simplified through non-core disposals, significantly
improving financial liquidity and reducing inherent overall business risk
· Invested across the core operating companies to support future
operating performance
· Bardsley closure process completed, with a loss of £0.6 million
in 2024 (2023: loss of £14.4 million)
· Strengthened operating company boards and management teams where
required, and restated Camellia's purpose
Post Year-End and Value Enhancement Plan:
· Further disposals of non-core property completed since year-end,
as well as disposal of Chulsa tea estate in India by Goodricke Group Limited
· Due to the harvesting cycles for the Group's major crops
occurring later in the year, it is premature to give guidance on crop
performance, market conditions and pricing for 2025 compared with 2024
· Following the comprehensive business review, a Value Enhancement
Plan covering the medium term will be announced in May 2025, outlining actions
to improve operating results, growth areas and capital allocation priorities
Byron Coombs, Chief Executive, commented:
"2024 saw a change in the Board and leadership at Camellia. The new directors
and management team bring a fresh perspective to the business and a focus on
business revitalisation. The principal objectives for 2024 were to strengthen
the balance sheet, reduce portfolio risk, update the Company's governance and
management processes, and initiate a review of the business strategy. We are
very pleased to report good progress on all four of these goals. In addition,
we have successfully exited our holdings in BF&M, United Finance and
United Insurance and disposed of several non-core assets. In doing so we
reduced the Group's risk profile and significantly improved financial
liquidity, enabling the Board to feel comfortable to recommend restarting the
dividend with confidence that this is sustainable. Our accomplishments in 2024
provide the Company with a cleaner and more robust platform from which it can
more ably address its challenges and deliver better results for its
shareholders and other stakeholders."
Financial Summary Table for 12 months ended 31 December 2024:
Financial Highlights 2024 2023
Continuing operations
Revenue £262.2m £254.2m
Trading loss* (£5.5m) (£10.3m)
Adjusted operating loss before tax (£4.8m) (£9.1m)
Separately disclosed significant items £7.0m £22.0m
Operating profit £2.2m £12.9m
Profit before tax £0.0m £18.2m
Taxation (£4.7m) (£5.2m)
(Loss) / profit after tax (£4.7m) £13.0m
Loss on discontinued operations (£0.6m) (£14.4m)
Loss after tax (£5.3m) (£1.4m)
Loss attributable to shareholders (£4.9m) (£3.7m)
(Loss) / Profit Per Share from Continuing Operations (155.7p) 387.4p
Loss Per Share from Continuing and Discontinued Operations (177.4p) (134.0p)
Total Dividend in respect of the financial year, subject to shareholder 260p Nil
approval at the 2025 Annual General Meeting
Net cash, treasury deposits and money market instruments* £124.7m £32.5m
Net Assets £347.7m £363.3m
Investment £9.5m £11.0m
* Additional performance measures, reconcilable in the financial statements
below.
The Group's 2024 annual report along with the notice of the AGM is now
available on the Group's website https://www.camellia.plc.uk, and will be
despatched to shareholders on or before 6 May 2025.
This announcement contains inside information under Article 7 of the Market
Abuse Regulation (EU) No. 596/2014, as part of UK domestic law via the
European Union (Withdrawal) Act 2018.
Enquiries:
Camellia
Plc
01622 746655 / investorrelations@camellia.co.uk
(mailto:investorrelations@camellia.co.uk)
Byron Coombs Chief Executive
Oliver Capon, Chief Financial Officer
Panmure Liberum (Nominated Adviser and Broker)
020 7886 2500
Emma Earl
Rupert Dearden
H/Advisers Maitland (Financial PR)
07785
292617
William
Clutterbuck
Investors can register to receive updates and news from the Company by
registering their email address at investorrelations@camellia.co.uk
(mailto:investorrelations@camellia.co.uk) .
Chairman's Statement
Throughout 2024, Camellia's operating companies continued to provide their
exceptional products and services worldwide, and the Board wishes to recognise
the dedication of everyone throughout the Group who has helped maintain its
reputation for both quality and integrity.
This year the Board was pleased to welcome three new members, Oliver Capon,
Alec Hayley, and Alison McFadyen. Oliver joined the Company as Chief Finance
Officer (CFO) Designate on 28 May 2024 and became CFO on 6 June 2024. He is an
experienced CFO with thirty years of experience, initially at Arthur Andersen
and subsequently at Shell Plc, where he worked in the UK and internationally.
Since his appointment, Oliver has brought to the executive team deep technical
and strategic capability, his significant international business experience,
strong commercial acumen, and extensive leadership skills. Alec and Alison
joined as Independent Non-Executive Directors and were appointed after the
2024 AGM. Alec is a Chartered Accountant and CFO with 30 years of experience
in the agriculture commodity sector in developed and emerging markets, with
significant management experience in the Company's key markets in Africa and
Asia. He holds an executive role at ECOM Agroindustrial Corporation Limited.
Alison has 40 years of international financial services experience, serving 22
years at Standard Chartered Plc, a FTSE 100 bank. Following her retirement in
2022, Alison has since served as a non-executive director of Standard
Chartered Bank. She has significant executive experience in a variety of
roles, latterly Group Head of Internal Audit at Standard Chartered Plc. Alison
holds a Masters of Business Administration and is a trustee of two performing
arts charities. Since their appointment in July 2024, Alec and Alison have
made significant contributions to the Board's effectiveness.
The Board is supported by our recently appointed Group General Counsel and
Company Secretary, Nischal Hindia. Nischal has 22 years of experience, has
practised law in India and the UK with a particular focus on mergers and
acquisitions, and held senior in-house legal and secretarial roles covering
the UK, India and Bangladesh including at Diageo, GlaxoSmithKline and Redx
Pharma.
The Board has been focusing on three key areas in 2024. The first was a
rigorous examination of the Group and the strategy through which Camellia will
look to prioritise actions and opportunities for value creation, growth, and
risk reduction. The second was a restatement of Camellia's purpose, values and
objectives, so that there could be no doubt as to what Camellia stands for,
and how it should operate. The third was a strengthening of governance,
embedding with greater clarity the model by which Camellia engages with the
operating companies, providing for operational autonomy while also providing
effective and appropriate mechanisms for support and constructive challenge.
With a very strong balance sheet and a renewed sense of purpose and direction
the Board has turned its focus from restoration to revitalisation. In this
regard I am pleased to report that the Board's medium-term review is
approaching its conclusion. The Company will look to communicate to investors
the outcome of this review during May 2025. Our goal is to provide investors
with a clearer understanding of Camellia's business strategy and prospects.
In the meantime, we would like to announce that, as a result of the Company's
improved liquidity and confidence in the Group's prospects, the Board has
proposed restarting the annual dividend with the confidence that this is
sustainable. The Board has, subject to shareholder approval, recommended a
final dividend for the financial year ending December 2024 of 260p/share. We
will comment further on our distribution strategy in May 2025.
The eminent business philosopher Charles Handy, who very sadly passed away at
the end of 2024, was a friend to Camellia over many years; he was an
exceptional man, whose integrity, humility and gentleness matched his
intellectual clarity and wisdom. Amongst the many matters he considered were
how businesses could best adapt where there was unpredictable social and
economic change, and the centrality of people to the purpose of business.
These ideas resonate clearly at this time, as momentous shifts such as climate
change, regional conflict, global trade disruption and broader geo-political
uncertainty significantly impact so many people worldwide. Camellia will
continue to address the opportunities and risks which a changing world
presents and to support its operating companies as they evolve and adapt to
new realities. In doing so, Camellia's objective remains to invest sustainably
for the long-term in harmony with the natural environment, serving both its
investors and the many communities of people its operating companies sustain.
The Board would like to sincerely thank all who work within the Group for
their considerable efforts this year. Their contributions in field, factory
and office make Camellia what it is.
Simon Turner
Chairman
Chief Executive's Statement
2024 saw a change in Board level leadership at Camellia. The appointment of a
new Chair and CEO in late 2023 was followed by the appointment of Oliver Capon
as Chief Financial Officer and Nischal Hindia as Group General Counsel and
Company Secretary, and two Independent non-executive Directors; Alec Hayley
and Alison McFadyen. The new Directors and management team bring a fresh
perspective to the business and a focus on business revitalisation.
The principal objectives for 2024 were to strengthen the balance sheet, reduce
portfolio risk, update the Company's governance and management processes, and
initiate a review of the business strategy. We are very pleased to report good
progress on all four of these goals. We successfully exited our holdings in
BF&M, United Finance and United Insurance, our three affiliates, and
disposed of several non-core assets. In doing so we reduced the Group's risk
profile and significantly improved financial liquidity, enabling the Board to
feel comfortable to recommend restarting the annual dividend with confidence
that this is sustainable. We also updated our governance processes, introduced
a new approach to business management and made good progress in assessing the
actions needed to return Camellia to operational profitability. In addition to
our four key objectives, we disposed of the remaining assets and liabilities
associated with the Bardsley business and initiated an on-market share
buy-back programme.
Our accomplishments in 2024 provide the Company with a cleaner and more robust
platform from which it can address challenges and deliver better results for
its shareholders and other stakeholders.
We are in the final stages of developing a medium-term plan for the Group and
expect to communicate the outcome of this review in May 2025. The Company's
primary goal is ensuring a sustainably profitable business for the long-term;
requiring both improved financial returns and lower structural risk.
Camellia is a portfolio of distinct businesses, and an important action in
2024 was to reinforce the sense of operational autonomy of our operating
company management teams while providing the required support and challenge.
Where required we supported the operating companies as they strengthened their
boards. We have taken the opportunity to mirror the new business management
structure in this report and accounts. We hope you find this new approach
clear and informative.
Group revenues from continuing activities in 2024 were £262 million, up from
£254 million in 2023. The trading result improved to a loss of £5.5 million
compared with a 2023 loss of £10.3 million. The Group's 2024 result before
tax from continuing operations was break even, benefitting from the net
profits arising from the sale of affiliates and other non-core assets,
compared to a profit of £18.2 million in 2023, which included a £19 million
impairment reversal. The Group generated net cash of £49.9 million in the
year compared to a cash outflow of £11.7 million in 2023. The balance sheet
at the end of 2024 was robust with net cash, term deposits and money market
investments of £124.7 million.
The primary agriculture industry has faced several challenges in the past few
years, but we are pleased to report that 2024 saw some improvement, and
potentially the beginning of a recovery from the post-Covid period of
inflation and weak prices. The Group's tea markets saw some price improvement
from the trough experienced in 2023, with the India tea market seeing a strong
uplift through most of the year. The macadamia market also showed signs of
price recovery, and the market for avocados and grains generally improved.
Beyond the agricultural businesses, AJT, the Aberdeen based engineering
company, implemented a number of operational changes and achieved
profitability for the first time in 10 years, and the luxury tea marketing
business, Jing, continued to show good growth while also undertaking important
platform changes and developing new packaging and branding which will launch
in 2025.
The 2024 financial results and the results of recent years are reflected in
our share price, which remains of concern to management and shareholders. We
would like to reiterate our reassurance from last year that the Camellia Board
recognises that returns from operations must improve. Over the past twelve
months the executive team has taken a number of actions designed to improve
Camellia's stability and profitability and will implement more changes during
2025 and beyond as part of our medium-term plan.
With our substantial cash resources, liquid investment portfolio and limited
gearing, we are also well placed to invest in business growth and operational
improvements. Our priority is to take the necessary actions to make Camellia a
financially successful and sustainable company over the long term. Achieving
this goal may result in the disposal of business units which we believe we are
not the best owner of, or which don't fit with our targeted lower risk
profile.
In conclusion, I would like to highlight the importance of Camellia's purpose
to both shareholders and other stakeholders. Our focus on financial
revitalisation must take place in the context of our purpose. Camellia will
work hard to build successful operating companies that support their employees
and their communities and take care of the environment where they operate. We
believe that achieving a good outcome for all stakeholders is central to
maintaining our license to operate, and crucially, to generating long-term
commercial value for our shareholders.
Byron Coombs
Chief Executive
Consolidated Profit and Loss Account
2024 2023
£'m £'m
Restated
Continuing operations
Revenue 262.2 254.2
Cost of sales (213.2 ) (205.3 )
Gross profit 49.0 48.9
Other operating income 2.4 2.7
Distribution costs (17.6 ) (20.1 )
Administrative expenses (39.3 ) (41.8 )
Trading loss (5.5 ) (10.3 )
Share of associates' results 0.2 3.4
Loss on disposal of associates (4.7 ) -
Profit on disposal of assets classified as held for sale 11.5 2.1
Profit on disposal of property and heritage assets 1.0 -
Impairments of intangible assets and investment properties (0.8 ) (1.6 )
Reversal of impairment of investment in associate - 19.0
Other gains and losses 0.2 -
Profit on disposal and fair value movements on money market investments 0.3 0.3
Operating profit 2.2 12.9
Investment income 2.8 2.9
Finance income 2.5 2.2
Finance costs (3.5 ) (2.8 )
Net exchange (loss)/gain (3.3 ) 3.4
Employee benefit expense (0.7 ) (0.4 )
Net finance (cost)/income (5.0 ) 2.4
Profit before tax - 18.2
Taxation (4.7 ) (5.2 )
(Loss)/profit for the year from continuing operations (4.7 ) 13.0
Discontinued operations
Loss for the year from discontinued operations (0.6 ) (14.4 )
Loss after tax (5.3 ) (1.4 )
(Loss)/profit attributable to:
Owners of Camellia Plc (4.9 ) (3.7 )
Non-controlling interests (0.4 ) 2.3
(5.3 ) (1.4 )
(Loss)/earnings per share - basic and diluted
From continuing operations (155.7 ) p 387.4 p
From continuing and discontinued operations (177.4 ) p (134.0 p
Note
Prior period comparatives have been restated following the reclassification of
Bardsley as a discontinued operation.
Consolidated Balance Sheet
31 December 31 December
2024 2023
£'m £'m
Restated
ASSETS
Non-current assets
Intangible assets 4.8 4.7
Property, plant and equipment 146.6 151.8
Right-of-use assets 12.6 12.5
Investment properties 13.9 23.3
Biological assets 15.2 11.2
Investments in associates - 10.4
Equity investments at fair value through other comprehensive income 30.4 30.6
Money market investments at fair value through profit or loss 4.3 6.5
Other investments - heritage assets 7.3 7.5
Trade and other receivables 2.2 2.7
Total non-current assets 237.3 261.2
Current assets
Inventories 46.9 49.4
Biological assets 7.8 8.8
Trade and other receivables 38.5 48.2
Money market investments at fair value through profit or loss 0.5 -
Debt investments at amortised cost - 1.0
Treasury deposits at amortised cost 39.9 -
Current income tax assets 0.5 0.9
Cash and cash equivalents (excluding bank overdrafts) 98.7 47.9
232.8 156.2
Assets classified as held for sale 6.2 82.3
Total current assets 239.0 238.5
LIABILITIES
Current liabilities
Financial liabilities - borrowings (15.6 ) (18.6 )
Lease liabilities (0.6 ) (2.2 )
Trade and other payables (55.3 ) (52.2 )
Current income tax liabilities (1.4 ) (1.6 )
Employee benefit obligations (0.4 ) (1.6 )
Provisions (7.5 ) (7.6 )
(80.8 ) (83.8 )
Liabilities related to assets classified as held for sale - (2.1 )
Total current liabilities (80.8 ) (85.9 )
Net current assets 158.2 152.6
Total assets less current liabilities 395.5 413.8
Non-current liabilities
Financial liabilities - borrowings (3.1 ) (3.3 )
Lease liabilities (7.6 ) (9.1 )
Deferred tax liabilities (28.0 ) (28.4 )
Employee benefit obligations (9.1 ) (9.7 )
Total non-current liabilities (47.8 ) (50.5 )
Net assets 347.7 363.3
EQUITY
Called up share capital 0.3 0.3
Share premium 15.3 15.3
Reserves 292.9 310.2
Equity attributable to owners of Camellia Plc 308.5 325.8
Non-controlling interests 39.2 37.5
Total equity 347.7 363.3
Consolidated Cashflow Statement
2024 2023
£'m £'m
Restated
Cash generated from/(used in) operations
Cash flows from operating activities 4.7 (10.3 )
Interest received 2.5 2.2
Interest paid (3.5 ) (1.7 )
Income taxes paid (5.9 ) (7.0 )
Contribution to defined benefit pension plan (1.0 ) -
Cash received from discontinued operation 6.5 -
Net cash generated from/(used) by operating activities 3.3 (16.8 )
Net cash (used by)/generated from discontinued operations (5.9 ) 1.9
Net cash flow used by operations (2.6 ) (14.9 )
Cash flows from investing activities
Purchase of intangible assets (0.1 ) -
Purchase of property, plant and equipment (9.4 ) (10.7 )
Proceeds from sale of non-current assets 4.2 1.2
Proceeds from sale of assets held for sale 82.2 0.3
Proceeds from the sale of associates 7.9 -
Biological assets: non-current - disposals 0.2 0.9
Proceeds from disposal of subsidiary - 16.6
Dividends received from associates 0.3 1.0
Acquisition of non-controlling interest (0.3) -
Purchase of investments (41.8 ) (6.1 )
Proceeds from sale of investments 5.7 4.1
Income from investments 2.8 2.9
Net cash generated from investing activities 51.7 10.2
Net cash generated from/(used by) investing activities - discontinued 6.3 (0.2 )
operations
Net cash flow from investing activities 58.0 10.0
Cash flows from financing activities
Equity dividends paid - (4.0 )
Purchase of own shares (0.2 ) -
Dividends paid to non-controlling interests (3.0 ) (2.6 )
New loans 0.9 4.8
Loans repaid (4.8 ) (2.0 )
Payments of lease liabilities (0.6 ) (0.4 )
Net cash flow from financing activities (7.7 ) (4.2 )
Net cash from financing activities - discontinued operations (1.3 ) (1.7 )
Net cash flow from financing activities (9.0 ) (5.9 )
Impact of hyperinflation (0.5 ) -
Net increase/(decrease) in cash and cash equivalents from continuing 46.8 (10.8 )
operations
Net cash outflow from discontinued operation (0.9 ) -
Cash and cash equivalents at beginning of period - continuing 32.8 44.5
Cash and cash equivalents at beginning of period - discontinued 1.1 1.1
Exchange gains/(losses) on cash 4.0 (0.9 )
Cash and cash equivalents at end of period - continuing 83.6 32.8
Cash and cash equivalents at end of period - discontinued 0.2 1.1
Cash and cash equivalents at end of period - total 83.8 33.9
Notes
1. Proposed dividend
The board has proposed a final dividend in respect of the 2024 financial year
of 260p per ordinary share, amounting to £7.1 million. Subject to
shareholders' approval at the 2025 annual general meeting, the dividend will
be paid on or after 31 July 2025 to shareholders on the register at the close
of business on 4 July 2025.
Ex-dividend date 3 July 2025
Record date 4 July 2025
Dividend payable on or after 31 July 2025
2. Basic and diluted earnings per share
The calculation of earnings per 10p share is based on:-
2024
Loss Weighted average number of shares EPS Profit / (Loss) Weighted average number of shares EPS
£'m
Pence
£'m
Pence
Basic and diluted EPS
Attributable to ordinary shareholders - continuing operations (4.3) 2,761,748 (155.7) 10.7 2,762,000 387.4
Attributable to ordinary shareholders - continuing and discontinued operations (4.9) 2,761,748 (177.4) (3.7) 2,762,000 (134.0)
3. Separately disclosed significant items
2024 2023
£'m £'m
Loss on disposal of associates (4.7) -
Profit on disposal of assets classified as held for sale 11.5 2.1
Profit on disposal of property and heritage assets 1.0 -
Impairments of intangible assets and investment properties (0.8) (1.6)
Reversal of impairment of investment in associate - 19.0
Release of creditor not required - 2.5
Separately disclosed significant items 7.0 22.0
4. Reconciliation of profit from operations to cash flow
2024 2023
(£'m)
(£'m)
Profit from operations 2.2 12.9
Share of associates' results (0.2) (3.4)
Depreciation and amortisation 9.1 10.1
Depreciation of right-of-use assets 0.7 0.8
Impairment of assets 0.8 1.6
Reversal of impairment of investment in associate - (19.0)
Realised movements on biological assets - non-current (2.2) (2.2)
Money market investments at fair value through profit or loss - gain (0.3) (0.3)
Other gains and losses (0.2) -
Profit on disposal of non-current assets (0.8) (0.1)
Loss on disposal of associates 4.7 -
Profit on disposal of assets classified as held for sale (11.5) (2.1)
Movement in provisions - (2.3)
Decrease/(increase) in inventories 0.8 (4.3)
Decrease in biological assets 1.2 0.6
Decrease/(increase) in trade and other receivables 7.3 (4.4)
(Decrease)/increase in trade and other payables (6.9) 1.8
Cash generated from/(used in) operations 4.7 (10.3)
5. Financial information
The financial information included in this announcement has been derived from
the Company's audited accounts but does not itself constitute statutory
accounts within the meaning of section 435 of the Companies Act 2006. The
statutory accounts for the financial year ended 31 December 2024 have been
reported on by the Group's auditor, Deloitte LLP, and will be filed with the
Registrar of Companies. The report of the auditors thereon was unqualified and
did not contain a statement under section 498(2) or (3) of the Companies Act
2006, nor did it contain any matters to which the auditors drew attention
without qualifying their audit report.
6. International Accounting Standards
This announcement is based on the Group's financial statements which were
prepared in accordance with UK-adopted International Accounting Standards.
7. 2024 annual report
The Group's 2024 annual report along with the notice of the annual general
meeting is available on the Group's website and will be despatched to
shareholders on or before 6 May 2025. Printed copies of the Group's 2024
annual report will be available from the Company at Wrotham Place, Bull Lane,
Wrotham, Near Sevenoaks, Kent TN15 7AE or via email from
investorrelations@camellia.co.uk (mailto:investorrelations@camellia.co.uk) .
The 2025 annual general meeting will be held on Thursday 5 June 2025.
By order of the board
Nischal Hindia
Company secretary
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END FR FKLLLEZLBBBXRecent news on Camellia
See all newsREG - Camellia PLC - Final Results
AnnouncementREG - Camellia PLC - Transaction in Own Shares
AnnouncementREG - Camellia PLC - Transaction in Own Shares
AnnouncementREG - Camellia PLC - Transaction in Own Shares
AnnouncementREG - Camellia PLC - Transaction in Own Shares
Announcement